封面
市场调查报告书
商品编码
1879920

全球血液凝固检验市场

Coagulation Testing

出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 171 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球血液凝固检验市场预计2030年将达到45亿美元。

全球血液凝固检验市场规模在2024年估计为34亿美元,预计2030年将达到45亿美元,在分析期间(2024-2030年)内复合年增长率(CAGR)为4.8%。本报告分析的细分市场之一-血液凝固检验耗材,预计将以5.1%的复合年增长率成长,并在分析期间结束时达到37亿美元。血液凝固检验设备细分市场预计在分析期间将以3.5%的复合年增长率成长。

美国市场规模估计为8.946亿美元,而中国市场预计将以7.3%的复合年增长率成长。

据估计,2024年美国血液凝固检验市场规模将达8.946亿美元。作为世界第二大经济体,中国预计到2030年市场规模将达到9.9亿美元,在2024年至2030年的分析期间内,复合年增长率(CAGR)将达到7.3%。其他值得关注的区域市场分析包括日本和加拿大,预计在分析期间内,这两个国家的复合年增长率将分别达到2.4%和4.7%。在欧洲,德国预计将以约2.9%的复合年增长率成长。

全球血液凝固检验市场-主要趋势与驱动因素概述

为什么血液凝固检验在现代医学中至关重要

血液凝固检验在现代医学中血液凝固检验至关重要的作用。这些检查用于评估血液的正常凝固能力,对于诊断出血性疾病、监测抗凝血治疗以及在手术过程中管理患者至关重要。正常的血液凝固对于预防过度出血至关重要,但凝血过程异常会导致严重的疾病,例如血栓症(过度凝血)和出血(凝血功能障碍)。血液凝固检验对​​于患有血友病和深层静脉栓塞症(DVT)等疾病的患者,或服用Warfarin等抗凝血药物的患者尤其重要。这些检查,包括凝血酶原时间(PT)、活化部份凝血活酵素时间(aPTT)和国际标准化比值(INR),为医生提供有关患者血液凝固能力的关键信息,从而能够及时诊断疾病并调整治疗方案。如果没有血液凝固检验,失控出血和凝血相关併发症的风险会显着增加,尤其是在高风险族群中,例如接受手术的人、创伤患者和患有慢性心血管疾病的人。

血液凝固检验为何如此先进可靠?

血液凝固检验是一个高度专业化的领域,因为它涉及对血液凝固速度和效率的精确测量,且过程复杂。现代凝血分析仪相比传统的手动方法有了显着的改进,并融合了先进技术,从而提高了准确性和效率。这些设备利用光学、机械或电化学系统即时测量血块的形成,提供快速可靠的结果。例如,光学方法检测凝血过程中血浆浊度的变化,而机械系统则追踪血块的物理运动。现代系统可以同时处理多个检测项目,并自动完成样本製备和试剂处理等步骤,从而减少人为误差,提高检查室的检测效率。除了硬体技术的进步外,试剂配方的创新也提高了血液凝固检验的敏感度和特异性。这使得检测凝血功能中细微的异常成为可能,这对于疑似患有轻度或早期凝血障碍的患者尤其重要。一些先进的分析仪还具备就地检验功能,使医护人员能够在检查室外进行血液凝固检验,例如在急诊室或长期接受抗凝血治疗的患者就诊期间。仪器和试剂化学的这些进步提高了血液凝固检验的可靠性,为医护人员提供了所需的精准度和效率,使他们能够自信地管理危重病患的病情。

在现代医学发展趋势的背景下,血液凝固检验正在发生怎样的变化?

为了应对日益增长的医疗需求和技术进步,血液凝固检验领域正在迅速发展。其中一个最显着的趋势是向照护现场(POC​​)的转变,这种检测方式无需在传统检查室环境下即可提供即时结果。这对于服用Warfarin等抗凝血药物的患者管理尤其重要,因为这类药物需要定期监测以调整剂量并避免併发症。携带式凝血分析仪使医护人员能够在诊所、家中甚至偏远地区进行检测,从而改善患者就医途径并减少就医次数。这一趋势与「个人化医疗」的理念相契合,后者旨在提供根据个别患者需求量身定制的医疗服务,而即时检测使这种方法更具可行性。另一个发展领域是将数位技术和数据分析融入血液凝固检验。许多现代分析仪都配备了软体,可以追踪患者的检测结果随时间的变化,提醒患者凝血活性发生显着变化,并为临床医生产生详细的报告。机器学习和人工智慧 (AI) 的应用也开始在血液凝固检验中发挥作用,AI 演算法能够根据检测结果、既往病历和其他健康数据预测患者预后。此外,新型生物标记和新一代试剂的开发,正在拓展血液凝固检验的范围,使其超越标准的 PT/INR 和 aPTT 检测。这些新检测方法能够更深入了解凝血途径,帮助医生诊断瀰漫性血管内凝血 (DIC) 等复杂疾病,并监测新型抗凝血疗法(例如直接口服抗凝血剂 (DOAC))的疗效。

哪些因素正在推动血液凝固检验市场的成长?

血液凝固检验市场的成长受多种因素驱动。其中一个关键驱动因素是全球心血管疾病盛行率的不断上升。这使得定期监测血液凝固功能变得特别重要,特别是对于有血栓症风险的患者以及接受抗凝血治疗的患者。随着中风、心肌梗塞和心房颤动等心血管疾病的日益普遍,对血液凝固检验的需求呈指数级增长。全球人口老化也是市场成长的重要因素。老年人更容易患有凝血功能障碍,因此需要定期进行静脉血栓栓塞症(VTE) 等疾病的检测,并进行抗凝血治疗管理。这种人口结构的变化正在持续推动对检查室检测和照护现场(POC)血液凝固检验解决方案的需求。此外,直接口服抗凝血剂 (DOAC) 的快速发展也扩大了凝血监测的范围。门诊诊所和居家医疗服务的兴起进一步推动了对便携式、易用型血液凝固检验设备的需求。由于其便利性和快速出结果的特性,就地检验在接受长期抗凝血治疗的患者中越来越受欢迎,而快速出结果对于调整药物剂量至关重要。另一个关键的成长要素是医疗基础设施投资的增加,尤其是在新兴市场。随着这些地区医疗体系的发展,对包括凝血分析仪在内的先进诊断工具的需求日益增长。各国政府和医疗机构正在投资建造最先进的检查室和诊断中心,以扩大医疗服务不足地区血液凝固检验的覆盖范围。最后,自动化、人工智慧整合和即时数据分析等技术进步正在提高血液凝固检验的准确性和速度。这些因素共同推动了血液凝固检验市场的成长,使其成为全球医疗保健体系中的关键组成部分。

部分:

产品(耗材、设备)、测试类型(能力验证、其他测试类型)、最终用途(医院/诊所、诊断检查室、居家医疗环境、其他最终用途)

受访公司范例

  • Abbott Laboratories, Inc.
  • Agappe Diagnostics Ltd.
  • Alere, Inc.
  • F. Hoffmann-La Roche AG
  • Helena Laboratories, Inc.
  • HemoSonics, LLC
  • Horiba, Ltd.
  • Medtronic PLC
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Universal Biosensors Inc.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具,改变您分析市场和竞争情报的方式。

Market Glass, Inc. 没有采用查询LLM 或产业专用的SLM 的常见做法,而是建立了一个由世界各地领域专家精心策划的内容库,其中包括视频转录、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中,Market Glass, Inc. 将关税对地理市场的影响纳入考量,并根据公司总部所在地、製造地以及进出口(成品和OEM产品)情况,预测企业竞争地位的变化。这种复杂多变的市场现实会从多个方面影响竞争对手,包括增加销货成本、降低盈利和重组供应链,同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 亚太其他地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP11116

Global Coagulation Testing Market to Reach US$4.5 Billion by 2030

The global market for Coagulation Testing estimated at US$3.4 Billion in the year 2024, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Coagulation Testing Instruments segment is estimated at 3.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$894.6 Million While China is Forecast to Grow at 7.3% CAGR

The Coagulation Testing market in the U.S. is estimated at US$894.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$990.0 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Coagulation Testing Market - Key Trends and Drivers Summarized

Why Is Coagulation Testing Essential in Modern Healthcare?

Coagulation testing plays a crucial role in modern healthcare. Coagulation tests are used to assess the blood's ability to clot properly and are critical for diagnosing bleeding disorders, monitoring anticoagulant therapy, and managing patients during surgical procedures. Proper blood clotting is essential for preventing excessive bleeding, but abnormalities in this process can lead to serious conditions such as thrombosis (excessive clotting) or hemorrhage (inability to clot). Coagulation tests are particularly important for patients with conditions like hemophilia, deep vein thrombosis (DVT), or those taking blood-thinning medications like warfarin. These tests, including prothrombin time (PT), activated partial thromboplastin time (aPTT), and international normalized ratio (INR), provide doctors with critical information about how well a patient’s blood coagulates, allowing for the timely diagnosis of disorders and adjustments in treatment plans. Without coagulation testing, the risk of uncontrolled bleeding or clotting-related complications would significantly increase, especially in high-risk populations such as those undergoing surgery, trauma victims, or patients with chronic cardiovascular diseases.

What Makes Coagulation Testing So Advanced and Reliable?

Coagulation testing is highly specialized due to the precision and complexity involved in measuring how quickly and efficiently blood clots. Modern coagulation analyzers have evolved significantly from traditional manual methods, incorporating advanced technologies that enhance both accuracy and efficiency. These devices use optical, mechanical, or electrochemical systems to measure clot formation in real-time, providing quick and reliable results. Optical methods, for example, detect changes in the turbidity of plasma as the clot forms, while mechanical systems track the physical movement of clots. Modern systems are also capable of handling multiple tests at once, automating processes such as sample preparation and reagent handling, thereby reducing human error and increasing throughput in laboratories. In addition to technological advancements in the hardware, innovations in reagent formulation have improved the sensitivity and specificity of coagulation tests. This ensures that even slight abnormalities in clotting can be detected, which is particularly important in patients who may have subtle or early-stage coagulation disorders. Some advanced analyzers are also equipped with point-of-care testing capabilities, allowing healthcare providers to perform coagulation tests outside the laboratory setting, such as in emergency rooms or during home visits for patients on long-term anticoagulation therapy. These advancements in both instrumentation and reagent chemistry make coagulation testing more reliable, offering healthcare providers the accuracy and efficiency needed to manage critical patient conditions with confidence.

How Is Coagulation Testing Evolving With Modern Healthcare Trends?

The landscape of coagulation testing is evolving rapidly in response to growing healthcare needs and technological advancements. One of the most significant trends is the shift toward point-of-care (POC) testing, which allows for immediate results outside traditional laboratory settings. This is particularly beneficial for managing patients on anticoagulants, such as warfarin, where regular monitoring is required to adjust dosages and avoid complications. Portable coagulation analyzers now allow healthcare providers to conduct these tests in clinics, at home, or even in remote locations, improving patient access to care and reducing the need for frequent hospital visits. This trend is aligned with the broader movement toward personalized medicine, where care is tailored to the individual patient’s needs, and POC testing helps make this approach more feasible. Another area of evolution is the integration of digital technologies and data analytics into coagulation testing. Many modern analyzers are equipped with software that can track patient results over time, flagging any significant changes in clotting ability and generating detailed reports for clinicians. The use of machine learning and artificial intelligence (AI) is also beginning to play a role in coagulation testing, with AI-powered algorithms helping to predict patient outcomes based on test results, past medical history, and other health data. Additionally, the development of novel biomarkers and next-generation reagents is expanding the scope of coagulation tests beyond standard PT/INR and aPTT measurements. These emerging tests provide deeper insights into coagulation pathways, helping physicians diagnose complex disorders such as disseminated intravascular coagulation (DIC) or monitor the effects of newer anticoagulant therapies like direct oral anticoagulants (DOACs).

What Is Driving the Growth of the Coagulation Testing Market?

The growth in the coagulation testing market is driven by several factors. One of the primary drivers is the increasing global prevalence of cardiovascular diseases, which necessitates regular monitoring of blood coagulation, particularly in patients at risk of thrombosis or those receiving anticoagulant therapy. As cardiovascular conditions such as stroke, heart attack, and atrial fibrillation become more common, the demand for coagulation testing is rising sharply. The aging global population is also a major contributor to market growth, as older adults are more likely to suffer from clotting disorders and require routine testing for conditions like venous thromboembolism (VTE) or to manage anticoagulant therapies. This demographic shift is creating a sustained demand for both laboratory-based and point-of-care coagulation testing solutions. Additionally, the rapid development of direct oral anticoagulants (DOACs) has expanded the scope of coagulation monitoring. The rise in outpatient care and home healthcare services is further driving the demand for portable and easy-to-use coagulation testing devices. Point-of-care testing is becoming increasingly popular among patients on long-term anticoagulation therapy, as it offers convenience and timely results, which are critical for adjusting medication dosages. Another significant growth driver is the increasing investment in healthcare infrastructure, particularly in emerging markets. As these regions develop their healthcare systems, the demand for sophisticated diagnostic tools, including coagulation analyzers, is rising. Governments and healthcare organizations are investing in state-of-the-art laboratories and diagnostic centers, expanding access to coagulation testing in underserved areas. Finally, technological advancements, including automation, AI integration, and real-time data analytics, are enhancing the accuracy and speed of coagulation testing. These combined factors are fueling the growth of the coagulation testing market, making it a vital component of the global healthcare landscape.

SCOPE OF STUDY:

The report analyzes the Coagulation Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables, Instruments); Test Type (PT, Other Test Types); End-Use (Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 38 Featured) -

  • Abbott Laboratories, Inc.
  • Agappe Diagnostics Ltd.
  • Alere, Inc.
  • F. Hoffmann-La Roche AG
  • Helena Laboratories, Inc.
  • HemoSonics, LLC
  • Horiba, Ltd.
  • Medtronic PLC
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Universal Biosensors Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Coagulation Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Cardiovascular Disorders Spurs Demand for Coagulation Testing
    • Aging Population Drives Growth in Coagulation Testing for Chronic Disease Management
    • Rising Adoption of Point-of-Care Testing (POCT) Expands the Addressable Market for Coagulation Testing Devices
    • Technological Innovations in Automated Coagulation Analyzers Propel Market Growth
    • Personalized Medicine and Precision Healthcare Strengthen the Business Case for Advanced Coagulation Testing
    • Here's How Direct Oral Anticoagulants (DOACs) Drive the Need for Specialized Coagulation Testing
    • Increasing Prevalence of Venous Thromboembolism (VTE) Accelerates Demand for Coagulation Screening
    • Expanding Global Healthcare Access in Emerging Economies Expands Market Opportunities for Coagulation Testing
    • Growing Awareness of Bleeding Disorders and Early Diagnosis Initiatives Drives Market Adoption of Coagulation Tests
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Coagulation Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Coagulation Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Coagulation Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Coagulation Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for PT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for PT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for PT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Coagulation Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Coagulation Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Coagulation Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Coagulation Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Coagulation Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Coagulation Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Coagulation Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Coagulation Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Coagulation Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Coagulation Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Coagulation Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Coagulation Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Coagulation Testing by Product - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Coagulation Testing by Product - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Coagulation Testing by Product - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Coagulation Testing by Test Type - PT and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Coagulation Testing by Test Type - PT and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Coagulation Testing by Test Type - Percentage Breakdown of Value Sales for PT and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Coagulation Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Coagulation Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic Laboratories, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION